QUEST DIAGNOSTICS INCORPORATED |
Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
| 134,3 USD | -0,86% |
|
+4,53% | -2,63% |
| 25/04 | Labcorp batte le stime trimestrali grazie alla forte domanda di test | RE |
| 24/04 | QUEST DIAGNOSTICS INCORPORATED : prospettiva positiva di Jefferies & Co. | ZM |
Attività
- test e servizi diagnostici (97,3%): test clinici di routine, test basati sui geni e servizi diagnostici avanzati e di anatomia patologica;
- altro (2,7%).
Numero di dipendenti: 44 000
Vendite per attività
| USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
|---|---|---|---|---|---|
Diagnostic Information Services
97,0
%
| 9 609 | 97,2 % | 8 976 | 97,0 % | -6,59% |
All Other
3,0
%
| 274 | 2,8 % | 276 | 3,0 % | +0,73% |
Vendite per regione
| USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
|---|---|---|---|---|---|
United States
100,0
%
| 9 883 | 100,0 % | 9 252 | 100,0 % | -6,38% |
Dirigenti
| Dirigenti | Titolo | Età | Da |
|---|---|---|---|
James Davis
CEO | Chief Executive Officer | 61 | 01/04/13 |
Sam Samad
DFI | Director of Finance/CFO | 54 | 11/07/22 |
Kristin Wallace
CMP | Compliance Officer | - | - |
| Chief Tech/Sci/R&D Officer | - | 18/02/19 | |
Shawn Bevec
IRC | Investor Relations Contact | - | - |
Sean Mersten
SEC | Corporate Secretary | - | - |
Mark Delaney
PRN | Corporate Officer/Principal | - | 01/03/22 |
Michael Deppe
AUD | Comptroller/Controller/Auditor | 59 | 01/01/98 |
Alyssa Waxenberg
PRN | Corporate Officer/Principal | 53 | 01/01/21 |
Doug Lang
PRN | Corporate Officer/Principal | - | 01/04/13 |
Amministratori
| Amministratori | Titolo | Età | Da |
|---|---|---|---|
Denise Morrison
BRD | Director/Board Member | 70 | 18/02/19 |
Timothy Ring
BRD | Director/Board Member | 66 | 07/12/11 |
Gail Wilensky
BRD | Director/Board Member | 80 | 01/01/97 |
Gary Pfeiffer
BRD | Director/Board Member | 74 | 01/12/04 |
Timothy Main
BRD | Director/Board Member | 66 | 13/01/14 |
Vicky Gregg
BRD | Director/Board Member | 69 | 22/07/14 |
Tracey Doi
BRD | Director/Board Member | 63 | 17/08/21 |
Wright Lassiter
BRD | Director/Board Member | 60 | 12/03/20 |
James Davis
CEO | Chief Executive Officer | 61 | 01/04/13 |
Luis Diaz
BRD | Director/Board Member | 53 | 17/05/23 |
Classe di azioni
| Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
|---|---|---|---|---|---|
| Azione A | 1 | 162 091 574 | 110 617 874 ( 68,24 %) | 51 000 000 ( 31,46 %) | 68,24 % |
Coordinate società
Società del gruppo
| Nome | Categoria e settore |
|---|---|
Blueprint Genetics Oy
 Blueprint Genetics Oy BiotechnologyHealth Technology Blueprint Genetics Oy engages in the provision of genetic diagnostics and clinical interpretation of hereditary diseases. It offer dignistic tests for cardiology; dermatology; endocrinology; immunology; metabolic disorder; nephrology; and pulmonology. The company was founded by Tommi Pietari Lehtonen, Juha Koskenvuo, Tero-Pekka Alastalo, and Samuel Myllykangas in 2008 and is headquartered in Helsinki, Finland. |
Biotechnology
|
Quest Diagnostics India Pvt Ltd.
 Quest Diagnostics India Pvt Ltd. Medical/Nursing ServicesHealth Services Quest Diagnostics India Pvt Ltd. provides pathology and clinical laboratory testing services. It offers employee life cycle approach, pre-employment screening, drug testing solutions, occupational exposure screening and monitoring blueprint for wellness driving healthy behavior & outcomes. The company is headquartered in Gurgaon, India. |
Medical/Nursing Services
|
Quest Diagnostics HTAS India Pvt Ltd.
|
Settore
Vendite per attività
Revisioni EPS
| Variaz. 1 gen. | Capi. | |
|---|---|---|
| -2,63% | 14,92 Mrd | |
| -14,92% | 84,68 Mrd | |
| +13,30% | 81,12 Mrd | |
| +10,92% | 29,4 Mrd | |
| -12,71% | 16,73 Mrd | |
| -3,06% | 16,36 Mrd | |
| -3,97% | 11,66 Mrd | |
| -1,42% | 11,72 Mrd | |
| -31,75% | 11,77 Mrd | |
| +27,44% | 11,71 Mrd |
- Borsa valori
- Azioni
- Azione DGX
- Società Quest Diagnostics Incorporated
